“Latest Stem Cells News”

The Health Minister recently held a press conference to launch a program to strengthen the public biobank network, considering that currently on 20% of donations are completed successfully. An informative pamphlet was also distributed about “The appropriate use of umbilical cord stem cells“.

The StemWay Biotech company, through its Vice-President Dr. Paolo Rubini, in complete agreement with other biobanks in Italy, with great surprise and dismay, stressed that unfortunately, the measure seems to be more against the autologous conservation of stem cells rather than in favor of donation. As for the scientific statements contained in the informative pamphlet distributed by the ministry, Dr. Rubini said that “without getting into the scientific details, which should not be outlined in a mass communication to the public, the scientific world has already expressed itself in the appropriate ways and even the FIOG, the Italian Federation of Obstetrics and Gynecology, has supported a biobank in the sector. It seems appropriate for me to highlight that based on internationally accepted scientific evidence, the Ministries of Health in the USA, Great Britain, Belgium, Austria, Holland, Norway, Dubai, India, Singapore, Switzerland, Hungary, and numerous other countries have adopted decisions that are completely different from those of the Italian Health Ministry, allowing private biobanks to operate and for the autologous conservation of stem cells.”

As for the possibility of gaining access to your own umbilical cord stem cells once you have decided to donate them as reported in the minister’s pamphlet, Dr. Rubini pointed out that: “if it is true that only about 20% of donations are successfully completed, it is evident that the 97% indicated by the Health Ministry can only be relative to these samples, and that the correct information to spread would be 97% of the 20% of the donors will have the possibility of accessing their own umbilical cord stem cells, and therefore in not more than 19.4% of the cases.” Finally, StemWay Biotech must emphasize that if the public biobank network is made up of about 100 facilities in the entire world, the choice to have 18 of them in Italy seems to be an anomaly in the use of public resources in the health sector, where it certainly cannot be said that it is a priority. “In this scenario,” said Dr. Rubini, “each citizen can easily make their own decisions regarding conservation and donation of umbilical cord stem cells and operate in the best way possible so this important biological asset is not lost in 95% of all births.”

from ADUC

Incoming search terms:

“More funds are necessary for research on amyotrophic lateral sclerosis (ALS). More resources to aid more serious and controlled research for cures that slow the degenerating effects of the disease, for example using stem cells”, said Claudio Sabelli, an ALS patient and member of the Board of the ‘Viva la Vita’ society, writing with a visually controlled computer that communicates for him, commenting about announcements on research to fight ALS.

Claudio Sabelli

Sabelli said, “As a patient, I have an opinion that is not supported by facts for the simple reason that there are no new developments. I believe that a lot of financing goes towards weak and inconsistent research ideas. I fear that false expectations like the Igf1 or lithium tests are damaging. It is true that without pinpointing the causes that trigger ALS it is impossible to find an efficient remedy, but it’s also true that in the meantime remedies that slow down its degenerating effects can be found. I am referring to all stem cells, including embryonic stem cells.” He added, “It is pointless to continue with useless arguments: stem cells represent a concrete possibility to cure serious pathologies. Research has to enjoy maximum freedom and autonomy.”

Incoming search terms: